The effects of chronic administration of tranylcypromine and rimonabant on behaviour and protein expression in brain regions of the rat

Pharmacology Biochemistry and Behavior

Volumn 100, Issue 3, 2012, Pages 506-512

  Assareh, Neda ^a   Elbatsh, Maha M ^a,b   Marsden, Charles A ^a   Kendall, David A ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b MENOUFIA UNIVERSITY   (Egypt)

Author keywords

Brain derived neurotrophic factor (BDNF); Depression; Endocannabinoids; Rimonabant; Tranylcypromine (TCP)

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; RIMONABANT; TRANYLCYPROMINE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; BODY WEIGHT; BRAIN REGION; CEREBELLUM; CHRONIC DRUG ADMINISTRATION; CONDITIONAL EMOTIONAL RESPONSE; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; FOOD INTAKE; FREEZING; FRONTAL CORTEX; GROOMING; HIPPOCAMPUS; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REARING; VELOCITY;

ANIMALS; ANTIDEPRESSIVE AGENTS; AVOIDANCE LEARNING; BEHAVIOR, ANIMAL; BRAIN-DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DEPRESSION; DRUG INVERSE AGONISM; FRONTAL LOBE; MALE; MONOAMINE OXIDASE INHIBITORS; MOTOR ACTIVITY; NERVE TISSUE PROTEINS; PHOSPHORYLATION; PIPERIDINES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PYRAZOLES; RANDOM ALLOCATION; RATS; RATS, INBRED STRAINS; RECEPTOR, CANNABINOID, CB1; SIGNAL TRANSDUCTION; TRANYLCYPROMINE;

RATTUS;

EID: 80855138211     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2011.10.017     Document Type: Article

References (56)

1. E.L. Abel Cannabis: effects on hunger and thirst Behav Biol 15 1975 255 281
2. P. Adamczyk, A. Golda, A.C. Mccreary, M. Filip, and E. Przegalinski Activation of endocannabinoid transmission induces antidepressant-like effects in rats J Physiol Pharmacol 59 2008 217 228 (Pubitemid 351955748)
3. C.A. Altar Neurotrophins and depression Trends Pharmacol Sci 20 1999 59 62
4. D.G. Amaral The primate amygdala and the neurobiology of social behavior: implications for understanding social anxiety Biol Psychiatry 51 2002 11 17 (Pubitemid 34093790)
5. Animal (Scientific Procedures) Act 1986. London: Her Majesty's Stationery Office, 1986.
6. D. Baker, G. Pryce, G. Giovannoni, and A.J. Thompson The therapeutic potential of cannabis Lancet Neurol 2 2003 291 298 (Pubitemid 38368569)
7. M. Bortolato, R.A. Mangieri, J. Fu, J.H. Kim, O. Arguello, A. Duranti, A. Tontini, M. Mor, G. Tarzia, and D. Piomelli Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress Biol Psychiatry 62 2007 1103 1110 (Pubitemid 350029716)
8. J.D. Bremner, J.H. Krystal, S.M. Southwick, and D.S. Charney Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies Synapse 23 1996 28 38 (Pubitemid 26138645)
9. R. Christensen, P.K. Kristensen, E.M. Bartels, H. Bliddal, and A. Astrup Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials Lancet 370 2007 1706 1713 (Pubitemid 350100788)
10. G. Colombo, R. Agabio, G. Diaz, C. Lobina, R. Reali, and G.L. Gessa Appetite suppression and weight loss after the cannabinoid antagonist SR 141716 Life Sci 63 1998 PL113 PL117
11. A.L. Coppell, Q. Pei, and T.S.C. Zetterström Bi-phasic change in BDNF gene expression following antidepressant drug treatment Neuropharmacology 44 2003 903 910 (Pubitemid 36515026)
12. V. Di Marzo, and I. Matias Endocannabinoid control of food intake and energy balance Nat Neurosci 8 2005 585 589 (Pubitemid 40594198)
13. A.G. Dulloo, and D.S. Miller Thermogenic drugs for the treatment of obesity: sympathetic stimulants in animal models Br J Nutr 52 1984 179
14. R.S. Duman Novel therapeutic approaches beyond the serotonin receptor Biol Psychiatry 44 1998 324 335 (Pubitemid 28432643)
15. A. Ennaceur, S. Michalikova, A. Bradford, and S. Ahmed Detailed analysis of the behavior of Lister and Wistar rats in anxiety, object recognition and object location tasks Behav Brain Res 159 2005 247 266 (Pubitemid 40462501)
16. M.S. Fanselow Conditional and unconditional components of post-shock freezing Integr Psychol Behav Sci 15 1980 177 182 (Pubitemid 11190893)
17. A. Ferrer, and F. Artigas Effects of single and chronic treatment with tranylcypromine on extracellular serotonin in rat brain Eur J Pharmacol 263 1994 227 234 (Pubitemid 24301300)
18. R.W. Foltin, M.W. Fischman, and M.F. Byrne Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory Appetite 11 1988 1 14
19. E.D. French [Delta] 9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors Neurosci Lett 226 1997 159 162 (Pubitemid 27201968)
20. A. Ghosh, and M.E. Greenberg Calcium signaling in neurons: molecular mechanisms and cellular consequences Science 268 1995 239 247
21. S. Gonzalez, J. Fernandez-Ruiz, V.D. Marzo, M. Hernandez, C. Arevalo, C. Nicanor, M.G. Cascio, E. Ambrosio, and J.A. Ramos Behavioral and molecular changes elicited by acute administration of SR141716 to [Delta]9- tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence Drug Alcohol Depend 74 2004 159 170 (Pubitemid 38501689)
22. J. Gray, G.S.H. Yeo, J.J. Cox, J. Morton, A.L.R. Adlam, J.M. Keogh, J.A. Yanovski, A. El Gharbawy, J.C. Han, and Y. Tung Hyperphagia, severe obesity, impaired cognitive function, and hyperactivity associated with functional loss of one copy of the brain-derived neurotrophic factor (BDNF) gene Diabetes 55 2006 3366
23. G. Griebel, J. Stemmelin, and B. Scatton Effects of the cannabinoid CB1 receptor antagonist rimonabant in models of emotional reactivity in rodents Biol Psychiatry 57 2005 261 267 (Pubitemid 40187370)
24. J. Haller, N. Bakos, M. Szirmay, C. Ledent, and T.F. Freund The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety Eur J Neurosci 16 2002 1395 1398 (Pubitemid 35340861)
25. M.N. Hill, and B.B. Gorzalka Is there a role for the endocannabinoid system in the etiology and treatment of melancholic depression? Behav Pharmacol 16 2005 333 352 (Pubitemid 41404805)
26. M.N. Hill, W.S.V. Ho, C.J. Hillard, and B.B. Gorzalka Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents J Neural Transm 115 2008 1673 1679
27. S.D. Iversen 5-HT and anxiety Neuropharmacology 23 1984 1553 1560 (Pubitemid 15152981)
28. S. Kathuria, S. Gaetani, D. Fegley, F. Valio, A. Duranti, A. Tontini, M. Mor, G. Tarzia, G.L. Rana, and A. Calignano Modulation of anxiety through blockade of anandamide hydrolysis Nat Med 9 2003 76 81 (Pubitemid 36098263)
29. J.E. Kelsey, and S. Calabro Rimonabant blocks the expression but not the development of locomotor sensitization to nicotine in rats Psychopharmacology 198 2008 461 466 (Pubitemid 351754670)
30. S.G. Kernie, D.J. Liebl, and L.F. Parada BDNF regulates eating behavior and locomotor activity in mice EMBO J 19 2000 1290 1300 (Pubitemid 30151025)
31. K.P. Lesch Serotonergic gene expression and depression: implications for developing novel antidepressants J Affect Disord 62 2001 57 76 (Pubitemid 32126612)
32. O. Lowry, N.J. Rosebrough, A.L. Rarr, and R.J. Randal Protein measurement with the Folin phenol reagent J Biol Chem 193 1951 265 275
33. Y. Maki, T. Inoue, T. Izumi, I. Muraki, K. Ito, Y. Kitaichi, X. Li, and T. Koyama Monoamine oxidase inhibitors reduce conditioned fear stress-induced freezing behavior in rats Eur J Pharmacol 406 2000 411 418
34. H.K. Manji, W.C. Drevets, and D.S. Charney The cellular neurobiology of depression Nat Med 7 2001 541 547 (Pubitemid 32448319)
35. J. Manzanares, J. Corchero, J. Romero, J.J. Fernández-Ruiz, J.A. Ramos, and J.A. Fuentes Pharmacological and biochemical interactions between opioids and cannabinoids Trends Pharmacol Sci 20 1999 287 294 (Pubitemid 29301682)
36. A. Mendiguren, and J. Pineda Systemic effect of cannabinoids on the spontaneous firing rate of locus coeruleus neurons in rats Eur J Pharmacol 534 2006 83 88 (Pubitemid 43384186)
37. T.W. Moody, Z. Merali, and J.N. Crawley The effects of anxiolytics and other agents on rat grooming behaviora Ann N Y Acad Sci 525 1988 281 290
38. L.L. Murphy, R.M. Munoz, B.A. Adrian, and M.A. Villanua Function of cannabinoid receptors in the neuroendocrine regulation of hormone secretion Neurobiol Dis 5 1998 432 446 (Pubitemid 29075843)
39. M. Nibuya, S. Morinobu, and R.S. Duman Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments J Neurosci 15 1995 7539 7547
40. M. Nibuya, E.J. Nestler, and R.S. Duman Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus J Neurosci 16 1996 2365 2372 (Pubitemid 26154346)
41. S. Patel, and C.J. Hillard Role of endocannabinoid signalling in anxiety and depression D.A. Kendall, S. Alexander, Current topics in behavioral neuroscience: behavioral neurobiology of the endocannabinoid system 2009 Springer-Verlag Berlin 347 371
42. M.A. Pelleymounter, M.J. Cullen, and C.L. Wellman Characteristics of BDNF-induced weight loss Exp Neurol 131 1995 229 238
43. F.X. Pi-Sunyer, L.J. Aronne, H.M. Heshmati, J. Devin, and J. Rosenstock Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial JAMA 295 2006 761
44. R.J. Rodgers, J. Haller, J. Halasz, and E. Mikics 'One trial sensitization'to the anxiolytic like effects of cannabinoid receptor antagonist SR141716A in the mouse elevated plus maze Eur J Neurosci 17 2003 1279 1286 (Pubitemid 36459782)
45. F.R. Rodriguez De Fonseca, M.A. Villanua, R.M. Munoz, O. San-Martin-Clark, and M. Navarro Differential effects of chronic treatment with either dopamine D1 or D2 receptor agonists on the acute neuroendocrine actions of the highly potent synthetic cannabinoid HU-210 in male rats Neuroendocrinology 61 1995 714 721
46. F. Rodriguez De Fonseca, P. Rubio, F. Menzaghi, E. Merlo-Pich, J. Rivier, G.F. Koob, and M. Navarro Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats J Pharmacol Exp Ther 276 1996 56 64
47. V. Santucci, J.-J. Storme, P. Soubrie, and G. Le Fur Arousal-enhancing properties of the CB1 cannabinoid receptor antagonist SR 141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis Life Sci 58 1996 PL103 PL110
48. A. Serrano, I. Del Arco, F. Javier Pavón, M. Macías, V. Perez-Valero, and F. Rodríguez De Fonseca The cannabinoid CB1 receptor antagonist SR141716A (Rimonabant) enhances the metabolic benefits of long-term treatment with oleoylethanolamide in Zucker rats Neuropharmacology 54 2008 226 234
49. P. Skolnick, B. Legutko, X. Li, and F.P. Bymaster Current perspectives on the development of non-biogenic amine-based antidepressants Pharmacol Res 43 2001 411 423
50. S.C. Stanford, and C.A. Marsden 5 Regional specialisation in the central noradrenergic response to unconditioned and conditioned environmental stimuli Tech. Behav Neural Sci 15 2005 487 501
51. US Food and Drug Administration Advisory Committee FDA briefing document: Zimulti (rimonabant) tablets, 20 mg available at: 2007 FDA Rockville http://www.fda.gov/OHRMS/DOCKETS/AC/07/briefing/2007-4306b1-00-index.htm (assessed 9 April, 2010)
52. R.I. Wilson, and R.A. Nicoll Endocannabinoid signaling in the brain Science 296 2002 678 682
53. J.M. Witkin, E.T. Tzavara, R.J. Davis, X. Li, and G.G. Nomikos A therapeutic role for cannabinoid CB1 receptor antagonists in major depressive disorders Trends Pharmacol Sci 26 2005 609 617 (Pubitemid 41636305)
54. B. Xu, E.H. Goulding, K. Zang, D. Cepoi, R.D. Cone, K.R. Jones, L.H. Tecott, and L.F. Reichardt Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor Nat Neurosci 6 2003 736
55. A. Zimmer, A.M. Zimmer, A.G. Hohmann, M. Herkenham, and T.I. Bonner Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice Proc Natl Acad Sci 96 1999 5780 5785 (Pubitemid 29234695)
56. R. Zini, J. Tillement, and D. Morin Effect of antidepressants on extracellular catecholamine concentrations in the rat hippocampus using in vivo microdialysis Biol Santé 1 2000 6 13